Influenza Vaccine Adjuvant to Improve Effectiveness of Flu Vaccine for Elders
Juvaris BioTherapeutics, Inc., a biotech company developing adjuvanted vaccines for infectious diseases, has begun enrolling patients in a Phase 2 clinical trial of JVRS-100, an adjuvant for seasonal influenza vaccines in the elderly population. Seasonal influenza affects approximately one billion people worldwide each year resulting in 5 million severe illnesses and 500,000 deaths. Approximately 90 [...]
